Trial intelligence / Profile preview

Letrozole vs MTX in Tubal Pregnancy

NCT05839561Completed

Sponsor
Jagiellonian University
Start
Dec 2020
Primary completion
Dec 2022
Modality
Orthosteric Ligands
Countries
1
01

Overview

Open-label trial of letrozole in Ectopic pregnancy (EP) (2 arms), sponsored by Jagiellonian University. Primary endpoint: Effectiveness of the treatment up to 6 months. Started Dec 2020; status: completed.

02

Drugs

letrozole
03

Conditions

Ectopic pregnancy (EP)

Beyond the preview

Go deeper on NCT05839561.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05839561.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call